EastWest Bioscience Has Profitability in Sight: Capital Ideas TV

Capital Ideas publisher Mark Bunting speaks with EastWest Bioscience (TSXV:EAST) CEO Rodney Gelineau


SmallCapPower partner Capital Ideas presents a special segment of Capital Ideas TV. In this episode, Capital Ideas Media publisher Mark Bunting sits down with Rodney Gelineau, CEO of EastWest Bioscience (TSXV:EAST), which just completed a reverse takeover with Harbour Star Capital. Rodney explains EAST’s strategy, gives revenue and profitability projections, and talks about EAST’s recent purchase of Sangster’s, a health store chain that’s been around since the early 1970s.

To read our full disclosure, please click on the button below: